{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:30:24Z","timestamp":1791203424848,"version":"4.2.0"},"reference-count":30,"publisher":"EDP Sciences","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1051\/medsci\/2009252161","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T06:26:28Z","timestamp":1299306388000},"page":"161-167","source":"Crossref","is-referenced-by-count":14,"title":["Interactions entre la Fibrilline-1 et le TGF-\u03b2"],"prefix":"10.1051","volume":"25","author":[{"given":"Julien","family":"Wipff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2009,2,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kDa glycoprotein, is a component of extracellular microfibrils.J Cell Biol1986; 103 : 2499\u2013509.","DOI":"10.1083\/jcb.103.6.2499"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Hollister DW, Godfrey M, Sakai LY, Pyeritz RE. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome.N Engl J Med1990; 323 : 152\u20139.","DOI":"10.1056\/NEJM199007193230303"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Magenis RE, Maslen CL, Smith L,et al.Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1.Genomics1991; 11 : 346\u201351.","DOI":"10.1016\/0888-7543(91)90142-2"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Kissin EY, Lemaire R, Korn JH, Lafyatis R. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation.Arthritis Rheum2002; 46 : 3000\u20139.","DOI":"10.1002\/art.10621"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor\/Smad signal transduction.Curr Opin Cell Biol2007; 19 : 176\u201384.","DOI":"10.1016\/j.ceb.2007.02.015"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.J Biol Chem1986; 261 : 4337\u201345.","DOI":"10.1016\/S0021-9258(17)35666-1"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Isogai Z, Ono RN, Ushiro S,et al.Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.J Biol Chem2003; 278 : 2750\u20137.","DOI":"10.1074\/jbc.M209256200"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Nunes I, Gleizes PE, Metz CN, Rifkin DB. Latent transforming growth factorb binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factorb.J Cell Biol1997; 136 : 1151\u201363.","DOI":"10.1083\/jcb.136.5.1151"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Collod-Beroud G, Le Bourdelles S, Ades L,et al.Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database.Hum Mutat2003; 22 : 199\u2013208.","DOI":"10.1002\/humu.10249"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Pereira L, Andrikopoulos K, Tian J,et al.Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.Nat Genet1997; 17 : 218\u201322.","DOI":"10.1038\/ng1097-218"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Neptune ER, Frischmeyer PA, Arking DE,et al.Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.Nat Genet2003; 33 : 407\u201311.","DOI":"10.1038\/ng1116"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Mizuguchi T, Collod-Beroud G, Akiyama T,et al.Heterozygous TGFBR2 mutations in Marfan syndrome.Nat Genet2004; 36 : 855\u201360.","DOI":"10.1038\/ng1392"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Loeys BL, Chen J, Neptune ER,et al.A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.Nat Genet2005; 37 : 275\u201381.","DOI":"10.1038\/ng1511"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"McGaha T, Saito S, Phelps RG,et al.Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.J Invest Dermatol2001; 116 : 136\u201343.","DOI":"10.1046\/j.1523-1747.2001.00217.x"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Sonnylal S, Denton CP, Zheng B,et al.Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.Arthritis Rheum2007; 56 : 334\u201344.","DOI":"10.1002\/art.22328"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Allanore Y, Wipff J, Kahan A, Boileau C. Genetic basis of systemic sclerosis.Joint Bone Spine2007; 74 : 577\u201383.","DOI":"10.1016\/j.jbspin.2007.04.005"},{"key":"R17","unstructured":"Wipff J, Giraud M, Sibilia J,et al.Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients.J Rheumatol2008; 4 : 643\u20139."},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Wallis DD, Tan FK, Kessler R,et al.Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma).Arthritis Rheum2004; 50 : 329\u201332.","DOI":"10.1002\/art.11437"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Tan FK, Arnett FC, Antohi S,et al.Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases.J Immunol1999; 163 : 1066\u201372.","DOI":"10.1002\/1529-0131(199912)42:12<2656::AID-ANR22>3.0.CO;2-N"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Snowden N, Coupes B, Herrick A,et al.Plasma TGF beta in systemic sclerosis: a cross-sectional study.Ann Rheum Dis1994; 53 : 763\u20137.","DOI":"10.1136\/ard.53.11.763"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Coker RK, Laurent GJ, Jeffery PK,et al.Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung.Thorax2001; 56 : 549\u201356.","DOI":"10.1136\/thorax.56.7.549"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Pannu J, Gore-Hyer E, Yamanaka M,et al.An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibitionviaa kinase-deficient transforming growth factor beta receptor type II in scleroderma.Arthritis Rheum2004; 50 : 1566\u201377.","DOI":"10.1002\/art.20225"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Dong C, Zhu S, Wang T,et al.Deficient Smad7 expression: a putative molecular defect in scleroderma.Proc Natl Acad Sci USA2002; 99 : 3908\u201313.","DOI":"10.1073\/pnas.062010399"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Denton CP, Merkel PA, Furst DE,et al.Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192.Arthritis Rheum2007; 56 :323\u201333.","DOI":"10.1002\/art.22289"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Sztrymf B, Yaici A, Girerd B, Humbert M. Genes and pulmonary hypertension.Respiration2007; 74 : 123\u201332.","DOI":"10.1159\/000098818"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Wipff J, Kahan A, Hachulla E,et al.Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension.Rheumatology (Oxford)2007; 46 : 622\u20135.","DOI":"10.1093\/rheumatology\/kel378"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Boileau C, Jondeau G, Mizuguchi T, Matsumoto N. Molecular genetics of Marfan syndrome.Curr Opin Cardiol2005; 20 : 194\u2013200.","DOI":"10.1097\/01.hco.0000162398.21972.cd"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Habashi JP, Judge DP, Holm TM,et al.Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.Science2006; 312 : 117\u201321.","DOI":"10.1126\/science.1124287"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Michel JB. Syst\u00e8me r\u00e9nine-angiotensine et remodelage vasculaire.Med Sci (Paris)2004; 20 : 409\u201313.","DOI":"10.1051\/medsci\/2004204409"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Campistol JM, Inigo P, Larios S,et al.Role of transforming growth factor-beta 1 in the progression of chronic allograft nephropathy.Nephrol Dial Transplant2001; 16 (suppl 1) : 114\u20136.","DOI":"10.1093\/ndt\/16.suppl_1.114"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2009252161\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T20:59:55Z","timestamp":1637355595000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2009252161"}},"subtitle":["Cons\u00e9quences en pathologie humaine"],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":30,"journal-issue":{"issue":"2"},"alternative-id":["medsci2009252p161"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2009252161","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}